Muhammed Zora

Dr. Muhammed Zora


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 September 2018 in Anesthesiology and Pain Medicine
Verified
Journal Article
Open access
PDF file
OOOzkan Onal
Ozkan Onal
IGIrem Gumus
Irem Gumus
MSMehmet SARI
Mehmet SARI
MZMuhammed Zora
Muhammed Zora
MAMehmet Ali Acar
Mehmet Ali Acar
Anesthesiology and Pain Medicine

21 March 2026 in BMC Anesthesiology
Verified
Journal Article
Open access
PDF file
MZMuhammed Zora
Muhammed Zora
YGYücel Gültekin
Yücel Gültekin
Preoperative anxiety is common among patients undergoing elective surgery and may influence postoperative recovery. Although preoperative counseling has be

2 February 2026 in PLOS ONE
Verified
Journal Article
Open access
EAEBRU ALADAG
EBRU ALADAG
MZMuhammed Zora
Muhammed Zora
The Pericapsular Nerve Group (PENG) block is a novel regional anesthesia technique that provides adequate analgesia while preserving motor function. This cross-sectional study evaluated the quality, reliability, and educational value of YouTube videos on the PENG block. Thirty-six videos were analyzed using validated scoring systems (GQS, JAMA, DISCERN, and modified DISCERN). Overall video quality was moderate, with higher scores observed in procedural and institutional videos. The findings highlight both the educational potential and the need for quality control in online medical content.

7 October 2026 in Journal of Imaging Informatics in Medicine
Verified
Journal Article
Closed access
PDF file
MZMuhammed Zora
Muhammed Zora
ÖSÖmer Sert
Ömer Sert

31 December 2022 in Genel Tıp Dergisi
Verified
Journal Article
Open access
PDF file
OIOmur Ilban
Omur Ilban
MZMuhammed Zora
Muhammed Zora
BABülent Devrim Akçay
Bülent Devrim Akçay
JCJale Bengi Celik
Jale Bengi Celik
FÇFaruk Çi̇çekci̇
Faruk Çi̇çekci̇
ADAtes Duman
Ates Duman
Aim: Hypothermia is a rare complication of antipsychotic drugs but serious outcomes including death may result. In this study, we aimed to investigate body temperature alterations in acute phase of chlorpromazine treatment, the relationship of inflammatory indicators and risk factors for hypothermic effect in intensive care unit (ICU) patients. Materials and methods: 63 intensive care patients who needed sedative treatment due to agitation were divided into two groups as Group 1 (n = 30) with temperatures ≤ 38°C, and Group 2 (n = 33) with temperatures > 38°C according to baseline body temperatures. Also, recurrent measurements for 12 hours were made at specific intervals following 25 mg intravenous chlorpromazine. Results: In Group 1, decrease in body temperatures was significant from 4th to 12th hours (p < 0.01), while in Group 2, significant decreases in body temperatures at all measurement hours were observed (p < 0.01). Temperature changes (delta temperature) observed at specific measurement intervals were significantly higher in Group 2 compared to Group 1. That difference was statistically significant at all intervals except for ΔTemperature B-6 (p < 0.05). The odds of hypothermic effects by chlorpromazine were 16%, 46%, 3%, and 18% for Acute Physiology and Chronic Health Evaluation II, procalcitonin, C-reactive protein, and white blood cells, respectively. Conclusion: Chlorpromazine treatment applied for agitation in ICU patients was associated with acute hypothermic effect. Severity of disease and comorbidities might increase risk of hypothermia, and inflammatory biomarkers might be predictors of adverse drug reaction.

23 August 2026 in Interdisciplinary Medical Journal
Verified
Journal Article
Closed access
MZMuhammed Zora
Muhammed Zora
ÖSÖmer Sert
Ömer Sert
Objective: This study aimed to investigate the relationship between pain experienced during propofol injection and patients’ socioeconomic status and state anxiety, while considering the effects of age, sex, body mass index, and time to loss of consciousness.Method: In this prospective, single-center observational study, adult patients undergoing anesthesia induction with propofol were included. Injection pain was evaluated within the first 30 seconds using a 0–10 visual analog scale. In addition, injection-related subjective sensations, including flushing, tingling, dizziness, taste disturbance, tinnitus, and pleasant sensations, were recorded as secondary outcomes. Socioeconomic status was determined using a composite score derived from education and income levels, and state anxiety was assessed with the six-item State–Trait Anxiety Inventory. The relationship between these variables and injection pain was examined using univariable and multivariable linear regression analyses. A sensitivity analysis including state anxiety was also performed. Results: A total of 106 patients were analyzed. In the multivariable analysis, higher body mass index (B = 0.318, 95% CI: 0.163–0.473; p < 0.001), longer time to loss of consciousness (B = 0.184, 95% CI: 0.124–0.244; p < 0.001), and female sex (B = 0.714, 95% CI: 0.110–1.318; p = 0.021) were independently associated with increased injection pain. Although socioeconomic status and state anxiety were associated with pain in the univariable analyses, these associations did not remain significant after adjustment for clinical covariates.Conclusion: The findings suggest that propofol injection pain is predominantly related to biological and procedural factors. After controlling for clinical variables, neither socioeconomic status nor preoperative state anxiety independently predicted the severity of pain.